TB-500 Fragment (17-23)

Buy TB-500 Fragment (17-23) Online

TB-500 Fragment 17-23 refers to the short peptide sequence associated with the 17-23 region of thymosin beta-4. It has attracted interest in peptide and analytical research because of its relationship to TB-500.

Product Information

Analytical research has identified the N-terminal acetylated 17-23 fragment of thymosin beta-4 in TB-500 formulations. The fragment is commonly identified as Ac-LKKTETQ.

How It Works

The 17-23 fragment represents a specific portion of thymosin beta-4 rather than the complete protein. Research has focused heavily on its identification, synthesis and analytical characteristics, while biological effects of isolated commercial fragments remain much less established.

POTENTIAL BENEFITS

1. Peptide Research

The fragment provides a defined peptide sequence for laboratory investigation and analytical characterization.

2. Thymosin Beta-4 Research

Because the sequence originates from thymosin beta-4, it is relevant to research exploring the biological properties of thymosin-derived peptides.

3. Analytical Research

The fragment has been specifically studied using mass-spectrometry-based techniques, making it useful for identification and detection research.

4. Peptide-Structure Research

Its defined amino-acid sequence makes the fragment relevant to studies of peptide synthesis, stability and molecular characterization.

Dosage

There is no established clinical dosage for TB-500 Fragment 17-23. Available literature does not provide a validated human dosing protocol for the isolated fragment.

Side Effects

Human safety data are insufficient. Potential reactions may include injection-site irritation, headache, dizziness, or other formulation-dependent effects.

References

• Esposito S, et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Testing and Analysis. 2012. PMID: 22962027. 22962027
• Philp D, et al. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. 2004. 15037013

Reference note: The first reference establishes the identification of the 17-23 fragment in TB-500. It does not establish clinical benefits or a therapeutic dose for the isolated fragment.

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.